InvestSMART

Nexalis Therapeutics Ltd (ASX: NX1) - Announcements

- Current share price for NX1 : $0.008

ASX company news and announcements for Nexalis Therapeutics Ltd (NX1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nexalis Therapeutics Ltd (NX1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nexalis Therapeutics Ltd (NX1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nexalis Therapeutics Ltd (NX1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2 Sep26 Appendix 4C Cash Flow Report 30 Oct 2026 9:09AM $0.009 $0.008 fallen by 11.11%
$2 Sep26 Quarterly Activities Report 30 Oct 2026 9:06AM $0.009 $0.008 fallen by 11.11%
$2 Proposed issue of securities - NX1 30 Oct 2026 8:57AM $0.009 $0.008 fallen by 11.11%
$2 Notification of cessation of securities - NX1 30 Oct 2026 8:52AM $0.009 $0.008 fallen by 11.11%
$2 Change of Director's Interest Notice - Darryl Davies 6 Oct 2026 12:40PM $0.015 $0.008 fallen by 46.67%
$2 Final Director's Interest Notice - Sean Williams 6 Oct 2026 12:03PM $0.015 $0.008 fallen by 46.67%
$2 Initial Director's Interest Notice - Niv Dagan 6 Oct 2026 12:02PM $0.015 $0.008 fallen by 46.67%
$2 Chair Appointment/Resignation 2 Oct 2026 10:01AM $0.015 $0.008 fallen by 46.67%
$2 Removal of draft wording in the directors report HY accounts 1 Sep 2026 3:46PM $0.009 $0.008 fallen by 11.11%
$2 Half Yearly Report and Accounts 31 Aug 2026 5:57PM $0.009 $0.008 fallen by 11.11%
$2 Jun26 Appendix 4C Cash Flow Report 31 Jul 2026 1:07PM $0.011 $0.008 fallen by 27.27%
$2 Jun26 Quarterly Activities Report 31 Jul 2026 1:06PM $0.011 $0.008 fallen by 27.27%
$2 Change in substantial holding 30 Jul 2026 11:02AM $0.011 $0.008 fallen by 27.27%
$2 Change of Director's Interest Notice - Sean Williams 14 Jul 2026 3:13PM $0.010 $0.008 fallen by 20%
$2 Change of Director's Interest Notice - Darryl Davies 14 Jul 2026 3:12PM $0.010 $0.008 fallen by 20%
$2 Notification of cessation of securities - NX1 14 Jul 2026 3:10PM $0.010 $0.008 fallen by 20%
$2 Notification regarding unquoted securities - NX1 14 Jul 2026 3:10PM $0.010 $0.008 fallen by 20%
$2 Issue of director share rights post shareholder approval 14 Jul 2026 3:06PM $0.010 $0.008 fallen by 20%
$2 Update on Funding Facility and Clinical Program 6 Jul 2026 11:48AM $0.010 $0.008 fallen by 20%
$2 Director Appointment/Resignation 25 Jun 2026 3:52PM $0.018 $0.008 fallen by 55.56%
$2 2026 AGM results 29 May 2026 6:23PM $0.023 $0.008 fallen by 65.22%
$2 2026 AGM slides 29 May 2026 4:14PM $0.023 $0.008 fallen by 65.22%
$2 Reinstatement to Official Quotation 28 May 2026 9:48AM $0.025 $0.008 fallen by 68%
$2 Binding Letter of Intent to replace existing $53m facility 28 May 2026 9:48AM $0.025 $0.008 fallen by 68%
$2 Suspension from Quotation 26 May 2026 10:34AM $0.025 $0.008 fallen by 68%

1 - 25 of 55 results

Page 1 of 3

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.